Palleon Co-Founder Dr. Carolyn Bertozzi wins a Nobel Prize in Chemistry for Pioneering Methods of Studying Glycobiology

Palleon Pharmaceuticals | 05 Jan 2023

We're excited to share Palleon Pharmaceuticals scientific co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in Chemistry.

Dr. Bertozzi’s deep contributions were not only to chemistry but to biology and medicine, including the foundational science underlying Palleon’s first-in-class, clinical-stage therapeutic platform. She also invented bioorthogonal chemistry which enabled foundational discoveries in glycobiology and pioneered translation of this field into a new area of drug development.

Check out our short clip on Palleon Pharmaceuticals and their scientific co-founder Carolyn Bertozzi below.

About Palleon Pharmaceuticals

Palleon Pharmaceuticals is a biotechnology company pioneering glyco-immunology drug development to transform the treatment of cancer and inflammatory diseases. Today, Palleon is advancing a rich clinical-stage pipeline of therapeutic candidates in immuno-oncology and inflammatory disorders which has the potential to impact millions of patients worldwide.

Find out more:

Vertex Ventures HC is part of the global Vertex Ventures network of funds.

In addition to the HC Fund, the Vertex Global Network is comprised of affiliates in Israel, China, Southeast Asia and India. Leveraging the combined experience and resources of our extensive partner network enables our portfolio companies to realize their full potential.

San Francisco

76 South Park Street
San Francisco, CA 94107
United States


One Broadway, 11th Floor
Cambridge, MA 02142
United States

© 2022 by Vertex Ventures. All rights reserved.